FindTrial
Sign In

A CLINICAL TRIAL TO STUDY THE EFFECTS OF DANAZOL ADMINISTERED VAGINALLY IN WOMEN WITH PELVIC PAIN DUE TO ENDOMETRIOSIS

EFFECT OF VAGINAL ADMINISTRATION OF DANAZOL IN PELVIC PAIN DUE TO ENDOMETRIOSIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000171
Enrollment
20
Registered
2010-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- women with endometriosis having pelvic pain

Interventions

Intervention1: vaginal danazol administration: 200 mg daily vaginally for 6 months. Control Intervention1: not applicable: not applicable

Sponsors

DrSMBhattacharya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.pelvic endometriosis (diagnosed by laparoscopy) causing pelvic pain 2.hormone therapies/ laparoscopic cauterisation not giving adequate relief from pain

Exclusion criteria

Exclusion criteria: 1. pain not due to endometriosis 2.unmarried girls where vaginal administration is not possible.

Design outcomes

Primary

MeasureTime frame
RELIEF FROM PELVIC PAIN- ASSESSED WITH VISUAL ANALOG SCALETimepoint: FIRST TIME OF ASSESSMENT- 3 MONTHS AFTER STARTING TREATMENT SECOND TIME OF ASSESSMENT- 6 MONTHS AFTER STARTING TREATMENT—

Secondary

MeasureTime frame
CHANGE IN LIVER FUNCTION TEST AND CHANGE IN PLASMA LIPIDSTimepoint: FIRST TIME OF ASSESSMENT- 3 MONTHS AFTER START OF TREATMENT SECOND TIME OF ASSESSMENT- 6 MONTHS AFTER START OF TREATMENT—

Countries

India

Contacts

Public ContactDRSUDHINDRA MOHAN BHATTACHARYA

CONSULTANT OBSTETRICIAN AND GYNAECOLOGIST

drsudhindra54@gmail.com033-24836330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026